Speaker illustration

Assistant Professor Ki-Woon Kang

Eulji University Hospital, Deajeon (Korea (Republic of))

B. Honors 2017 Early Career Research Award, Heart Rhythm Scientific Session, USA 2015 Heart Rhythm Journal Outstanding Publication Awards, Heart Rhythm Society, USA C. Personal Statement As a basic and clinical experienced cardiologist, My interest has focused on complex pathophysiology of its cardiovascular disorders with integrated genetic, molecular and electrophysiologic mechanism and been investigating to find the novel mechanism, predictors and novel treatment modulation to improve diseased cardiac structure, function and its conduction system including its related pacing-induced cardiomyopathy, atrial or ventricular fatal arrhythmia, ischemic heart failure, syncope and sudden cardiac death. In addition, the “bench to bedside” approach of my enthusiasm and scientific approach will provide a powerful understanding of current clinical limitations and prioritize investigation accordingly to find the necessary modalities to improve clinical outcomes in this growing and complex c

Arterial pH and hemoglobin regardless of amiodarone and emergent intervention is a major determinant for survival on the return of spontaneous circulation of the out-of hospital cardiac arrest

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Technical aspects (Sudden cardiac death and implantable defibrillators)

Session: Poster Session 2 - 41st EWGCCE Meeting

Thumbnail

Rate control strategy in the nonvalvular atrial fibrillation with reduced and preserved heart failure: analysis of a multicenter registry

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Mechanisms (Atrial Fibrillation)

Session: Atrial Fibrillation - Mechanisms

Thumbnail

Pacing QRS duration is a major determinant for occurrence of pacing-induced cardiomyopathy in the complete AV block over 15-year periods: multicenter study

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Devices (Pacing)

Session: Rapid Fire session 2 - Cardiac pacing, syncope and monitoring

Thumbnail

This platform is supported by

logo Novo Nordisk